Hydrogen peroxide-induced apoptosis mediated by p53 protein in glial cells

GLIA

Volumn 25, Issue 2, 1999, Pages 154-164

  Kitamura, Yoshihisa ^a   Ota, Takashi ^a   Matsuoka, Yasuji ^a   Tooyama, Ikuo ^b   Kimura, Hiroshi ^b   Shimohama, Shun ^c   Nomura, Yasuyuki ^d   Gebicke Haerter, Peter J ^e   Taniguchi, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e Kyoto Pharmaceutical Univ M ^*

Author keywords

Bak; GADD45; Human glioblastoma cells; Oxidative stress; p21(WAF1 CIP1); p53 deficient mouse

Indexed keywords

DNA FRAGMENT; HYDROGEN PEROXIDE; OXIDIZING AGENT; PROTEIN P53;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CELL CULTURE; CELL SURVIVAL; DNA DAMAGE; DRUG EFFECT; ELECTRON MICROSCOPY; GENETICS; GLIA; GLIOBLASTOMA; HUMAN; MALE; MOUSE; NICK END LABELING; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL SURVIVAL; DNA DAMAGE; DNA FRAGMENTATION; GLIOBLASTOMA; HUMANS; HYDROGEN PEROXIDE; IN SITU NICK-END LABELING; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; NEUROGLIA; OXIDANTS; OXIDATIVE STRESS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033555360     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(19990115)25:2<154::AID-GLIA6>3.0.CO;2-S     Document Type: Article

References (49)

1. AndersonAJ, Su JH, Cotman CW. 1996. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 16:1710-1719.
2. Behl C, Davis JB, Lesley R, Schubert D. 1994a. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
3. Behl C, Davis JB, Klier FG, Schubert D. 1994b. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res 645:253-264.
4. Bögler O, Huang HS, Cavenee WK. 1995. Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation. Cancer Res 55:2746-2751.
5. Chen X, Ko LJ, Jayaraman L, Prives C. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438-2451.
6. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
7. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. 1992. p53 Mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52:674-679.
8. Gerlai R. 1996. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 19:177-181.
9. Giard DJ, Aaronson SA, Todaro GJ, Amstein P, Kersey JH, Dosik H, Parks WP. 1973. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51:1417-1423.
10. Gottlieb TM, Oren M. 1996. p53 in growth control and neoplasia. Biochim Biophys Acta 1287:77-102.
11. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-616.
12. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 Mutations in human cancers. Science 253:49-53.
13. Jordán J, Galindo MF, Prehn JHM, Weichselbaum RR, Beckett M, Ghadge GD, Roos RP, Leiden JM, Miller RJ. 1997. p53 expression induces apoptosis in hippocampal pyramidal neuron cultures. J Neurosci 17:1397-1405.
14. Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T. 1997. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 232:418-421.
15. Kitamura Y, Furukawa M, Matsuoka Y, Tooyama I, Kimura H, Nomura Y, Taniguchi T. 1998a. In vitro and in vivo induction of heme oxygenase-1 in rat glial cells: possible involvement of nitric oxide production from inducible nitric oxide synthase. Glia 22:138-148.
16. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, Taniguchi T. 1998b. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res 780:260-269.
17. Knudson CM, Tung KSK, Tourtellotte WG, Brown GA, Korsmeyer SJ. 1995. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96-99.
18. Ko LJ, Prives C. 1996. p53: puzzle and paradigm. Genes Dev 10:1054-1072.
19. Labourdette G, Sensenbrenner M. 1995. Growth factors and their receptors in the central nervous system. In: Kettenmann H, Ransom BR, editors. Neuroglia. New York: Oxford University Press. p 441-459.
20. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM. 1995. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89:35-41.
21. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. 1993. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951-7955.
22. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849.
23. Ludwin SK. 1990. Oligodendrocyte survival in Wallerian degeneration. Acta Neuropathol 80:184-191.
24. Martinou I, Missotten M, Fernandez P-A, Sadoul R, Martinou J-C. 1998. Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons. NeuroReport 9:15-19.
25. Matsumoto H, Shimura M, Omatsu T, Okaichi K, Mijima H, Ohnishi T. 1994. p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines. Cancer Lett 87:39-46.
26. Matsumoto H, Wang X, Ohnishi T. 1995. Binding between wild-type p53 and hsp72 accumulated after UV and γ-ray irradiation. Cancer Lett 92:127-133.
27. Matsuoka Y, Kitamura Y, Okazaki M, Kakimura J, Tooyama I, Kimura H, Taniguchi T. 1998. Kainic acid induction of heme oxygenase in vivo and in vitro. Neuroscience 85:1223-1233.
28. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. 1993. Microglia in degenerative neurological disease. Glia 7:84-92.
29. McShea A, Harris PLR, Webster KR, Wahl AF, Smith MA. 1997. Abnormal expression of the cell cycle regulators p16 and CDK4 in Alzheimer's disease. Am J Pathol 150:1933-1939.
30. Miller TM, Moulder KL, Knudson CM, Creedon DJ, Deshmukh M, Korsmeyer SJ, Johnson EM Jr. 1997. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J Cell Biol 139:205-217.
31. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
32. Miyashita T, Reed JC. 1995. Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell 80:293-299.
33. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA. 1996. Loss of the p53 tumor suppressor gene products neurons from kinate-induced cell death. J Neurosci 16: 1337-1345.
34. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
35. Nedergaard M. 1994. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 263:1768-1771.
36. Polyak K, Waldman T, He T-C, Kinzler KW, Vogelstein B. 1996. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10:1945-1952.
37. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. 1997. A model for p53-induced apoptosis. Nature 389:300-305.
38. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T. 1995. A subset of p53-deficient embryos exhibit exencephaly. Nature Genet 10:175-180.
39. Schauwecker PE, Steward O. 1997. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci USA 94:4103-4108.
40. Simonian NA, Coyle JT. 1996. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36:83-106.
41. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE Jr. 1995. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133:225-230.
42. Smith MA, Sayre LM, Monnier VM, Perry G. 1995. Radical AGEing Alzheimer's disease. Trends Neurosci 18:172-176.
43. Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr. 1994. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266:1376-1380.
44. Tsukada T, Tomooka Y, Takai S, Ueda Y, Nishikawa S, Yagi T, Tokunaga T, Takeda N, Suda Y, Abe S, Matsuo I, Ikawa Y, Aizawa S. 1993. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8:3313-3322.
45. West MJ, Coleman PD, Flood DG, Troncoso JC. 1994. Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease. Lancet 344:769-772.
46. Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Schwartzkroin PA, Morrison RS. 1998. Bax involvement in p53-mediated neuronal cell death. J Neurosci 18:1363-1373.
47. Yahanda AM, Bruner JM, Donehower LA, Morrison RS. 1995. Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol Cell Biol 15:4249-4259.
48. Yang G, Kitagawa K, Matsushita K, Mabuchi T, Yagita Y, Yanagihara T, Matsumoto M. 1997. C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: selective neuronal death in the murine transient forebrain ischemia. Brain Res 752:209-218.
49. Yankner BA. 1996. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932.